img

Oncology Companion Diagnostic


Published on: 2024-01-04 | No of Pages : 137 | Industry : Pharma & Healthcare

Publisher : MRA Reports | Format : PDF&Excel

Oncology Companion Diagnostic

The global Oncology Companion Diagnostic market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on MRA Reports newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).



By Market Verdors

Agilent Technologies, Inc.

Myriad Genetics, Inc.

Thermo Fisher Scientific Inc.

Illumina, Inc.

Abbott

Qiagen N.V.

Invivoscribe, Inc.

ARUP Laboratories

F. Hoffmann-La Roche Ltd.

bioMérieux SA



By Types

Polymerase Chain Reaction (PCR)

Next-Generation Sequencing (NGS)

Immunohistochemistry (IHC)

In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)

Others



By Applications

Hospital

Pathology/Diagnostic Laboratory

Academic Medical Center



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Oncology Companion Diagnostic Revenue

1.5 Market Analysis by Type

1.5.1 Global Oncology Companion Diagnostic Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Polymerase Chain Reaction (PCR)

1.5.3 Next-Generation Sequencing (NGS)

1.5.4 Immunohistochemistry (IHC)

1.5.5 In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH)

1.5.6 Others

1.6 Market by Application

1.6.1 Global Oncology Companion Diagnostic Market Share by Application: 2022-2027

1.6.2 Hospital

1.6.3 Pathology/Diagnostic Laboratory

1.6.4 Academic Medical Center

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Oncology Companion Diagnostic Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Oncology Companion Diagnostic Market Players Profiles

3.1 Agilent Technologies, Inc.

3.1.1 Agilent Technologies, Inc. Company Profile

3.1.2 Agilent Technologies, Inc. Oncology Companion Diagnostic Product Specification

3.1.3 Agilent Technologies, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Myriad Genetics, Inc.

3.2.1 Myriad Genetics, Inc. Company Profile

3.2.2 Myriad Genetics, Inc. Oncology Companion Diagnostic Product Specification

3.2.3 Myriad Genetics, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Thermo Fisher Scientific Inc.

3.3.1 Thermo Fisher Scientific Inc. Company Profile

3.3.2 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Specification

3.3.3 Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Illumina, Inc.

3.4.1 Illumina, Inc. Company Profile

3.4.2 Illumina, Inc. Oncology Companion Diagnostic Product Specification

3.4.3 Illumina, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Abbott

3.5.1 Abbott Company Profile

3.5.2 Abbott Oncology Companion Diagnostic Product Specification

3.5.3 Abbott Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Qiagen N.V.

3.6.1 Qiagen N.V. Company Profile

3.6.2 Qiagen N.V. Oncology Companion Diagnostic Product Specification

3.6.3 Qiagen N.V. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Invivoscribe, Inc.

3.7.1 Invivoscribe, Inc. Company Profile

3.7.2 Invivoscribe, Inc. Oncology Companion Diagnostic Product Specification

3.7.3 Invivoscribe, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 ARUP Laboratories

3.8.1 ARUP Laboratories Company Profile

3.8.2 ARUP Laboratories Oncology Companion Diagnostic Product Specification

3.8.3 ARUP Laboratories Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 F. Hoffmann-La Roche Ltd.

3.9.1 F. Hoffmann-La Roche Ltd. Company Profile

3.9.2 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Specification

3.9.3 F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 bioMérieux SA

3.10.1 bioMérieux SA Company Profile

3.10.2 bioMérieux SA Oncology Companion Diagnostic Product Specification

3.10.3 bioMérieux SA Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Oncology Companion Diagnostic Market Competition by Market Players

4.1 Global Oncology Companion Diagnostic Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Oncology Companion Diagnostic Revenue Market Share by Market Players (2016-2021)

4.3 Global Oncology Companion Diagnostic Average Price by Market Players (2016-2021)

5 Global Oncology Companion Diagnostic Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Oncology Companion Diagnostic Market Size (2016-2021)

5.1.2 Oncology Companion Diagnostic Key Players in North America (2016-2021)

5.1.3 North America Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.1.4 North America Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Oncology Companion Diagnostic Market Size (2016-2021)

5.2.2 Oncology Companion Diagnostic Key Players in East Asia (2016-2021)

5.2.3 East Asia Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.2.4 East Asia Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Oncology Companion Diagnostic Market Size (2016-2021)

5.3.2 Oncology Companion Diagnostic Key Players in Europe (2016-2021)

5.3.3 Europe Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.3.4 Europe Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Oncology Companion Diagnostic Market Size (2016-2021)

5.4.2 Oncology Companion Diagnostic Key Players in South Asia (2016-2021)

5.4.3 South Asia Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.4.4 South Asia Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Oncology Companion Diagnostic Market Size (2016-2021)

5.5.2 Oncology Companion Diagnostic Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.5.4 Southeast Asia Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Oncology Companion Diagnostic Market Size (2016-2021)

5.6.2 Oncology Companion Diagnostic Key Players in Middle East (2016-2021)

5.6.3 Middle East Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.6.4 Middle East Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Oncology Companion Diagnostic Market Size (2016-2021)

5.7.2 Oncology Companion Diagnostic Key Players in Africa (2016-2021)

5.7.3 Africa Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.7.4 Africa Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Oncology Companion Diagnostic Market Size (2016-2021)

5.8.2 Oncology Companion Diagnostic Key Players in Oceania (2016-2021)

5.8.3 Oceania Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.8.4 Oceania Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Oncology Companion Diagnostic Market Size (2016-2021)

5.9.2 Oncology Companion Diagnostic Key Players in South America (2016-2021)

5.9.3 South America Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.9.4 South America Oncology Companion Diagnostic Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Oncology Companion Diagnostic Market Size (2016-2021)

5.10.2 Oncology Companion Diagnostic Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Oncology Companion Diagnostic Market Size by Type (2016-2021)

5.10.4 Rest of the World Oncology Companion Diagnostic Market Size by Application (2016-2021)

6 Global Oncology Companion Diagnostic Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Oncology Companion Diagnostic Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Oncology Companion Diagnostic Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Oncology Companion Diagnostic Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Oncology Companion Diagnostic Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Oncology Companion Diagnostic Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Oncology Companion Diagnostic Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Oncology Companion Diagnostic Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Oncology Companion Diagnostic Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Oncology Companion Diagnostic Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Oncology Companion Diagnostic Consumption by Countries

7 Global Oncology Companion Diagnostic Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Oncology Companion Diagnostic (2022-2027)

7.2 Global Forecasted Revenue of Oncology Companion Diagnostic (2022-2027)

7.3 Global Forecasted Price of Oncology Companion Diagnostic (2022-2027)

7.4 Global Forecasted Production of Oncology Companion Diagnostic by Region (2022-2027)

7.4.1 North America Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.3 Europe Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.7 Africa Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.9 South America Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Oncology Companion Diagnostic Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Oncology Companion Diagnostic by Application (2022-2027)

8 Global Oncology Companion Diagnostic Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Oncology Companion Diagnostic by Country

8.2 East Asia Market Forecasted Consumption of Oncology Companion Diagnostic by Country

8.3 Europe Market Forecasted Consumption of Oncology Companion Diagnostic by Countriy

8.4 South Asia Forecasted Consumption of Oncology Companion Diagnostic by Country

8.5 Southeast Asia Forecasted Consumption of Oncology Companion Diagnostic by Country

8.6 Middle East Forecasted Consumption of Oncology Companion Diagnostic by Country

8.7 Africa Forecasted Consumption of Oncology Companion Diagnostic by Country

8.8 Oceania Forecasted Consumption of Oncology Companion Diagnostic by Country

8.9 South America Forecasted Consumption of Oncology Companion Diagnostic by Country

8.10 Rest of the world Forecasted Consumption of Oncology Companion Diagnostic by Country

9 Global Oncology Companion Diagnostic Sales by Type (2016-2027)

9.1 Global Oncology Companion Diagnostic Historic Market Size by Type (2016-2021)

9.2 Global Oncology Companion Diagnostic Forecasted Market Size by Type (2022-2027)

10 Global Oncology Companion Diagnostic Consumption by Application (2016-2027)

10.1 Global Oncology Companion Diagnostic Historic Market Size by Application (2016-2021)

10.2 Global Oncology Companion Diagnostic Forecasted Market Size by Application (2022-2027)

11 Global Oncology Companion Diagnostic Manufacturing Cost Analysis

11.1 Oncology Companion Diagnostic Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Oncology Companion Diagnostic

12 Global Oncology Companion Diagnostic Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Oncology Companion Diagnostic Distributors List

12.3 Oncology Companion Diagnostic Customers

12.4 Oncology Companion Diagnostic Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Oncology Companion Diagnostic Revenue (US$ Million) 2016-2021

Table 6. Global Oncology Companion Diagnostic Market Size by Type (US$ Million): 2022-2027

Table 7. Polymerase Chain Reaction (PCR) Features

Table 8. Next-Generation Sequencing (NGS) Features

Table 9. Immunohistochemistry (IHC) Features

Table 10. In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH) Features

Table 11. Others Features

Table 16. Global Oncology Companion Diagnostic Market Size by Application (US$ Million): 2022-2027

Table 17. Hospital Case Studies

Table 18. Pathology/Diagnostic Laboratory Case Studies

Table 19. Academic Medical Center Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Oncology Companion Diagnostic Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Oncology Companion Diagnostic Market Growth Strategy

Table 46. Oncology Companion Diagnostic SWOT Analysis

Table 47. Agilent Technologies, Inc. Oncology Companion Diagnostic Product Specification

Table 48. Agilent Technologies, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Myriad Genetics, Inc. Oncology Companion Diagnostic Product Specification

Table 50. Myriad Genetics, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Product Specification

Table 52. Thermo Fisher Scientific Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Illumina, Inc. Oncology Companion Diagnostic Product Specification

Table 54. Table Illumina, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Abbott Oncology Companion Diagnostic Product Specification

Table 56. Abbott Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Qiagen N.V. Oncology Companion Diagnostic Product Specification

Table 58. Qiagen N.V. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Invivoscribe, Inc. Oncology Companion Diagnostic Product Specification

Table 60. Invivoscribe, Inc. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. ARUP Laboratories Oncology Companion Diagnostic Product Specification

Table 62. ARUP Laboratories Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Product Specification

Table 64. F. Hoffmann-La Roche Ltd. Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. bioMérieux SA Oncology Companion Diagnostic Product Specification

Table 66. bioMérieux SA Oncology Companion Diagnostic Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Oncology Companion Diagnostic Production Capacity by Market Players

Table 148. Global Oncology Companion Diagnostic Production by Market Players (2016-2021)

Table 149. Global Oncology Companion Diagnostic Production Market Share by Market Players (2016-2021)

Table 150. Global Oncology Companion Diagnostic Revenue by Market Players (2016-2021)

Table 151. Global Oncology Companion Diagnostic Revenue Share by Market Players (2016-2021)

Table 152. Global Market Oncology Companion Diagnostic Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 155. North America Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 157. North America Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 159. East Asia Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 162. East Asia Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 164. East Asia Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 166. Europe Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 169. Europe Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 171. Europe Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 173. South Asia Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 176. South Asia Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 178. South Asia Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 180. Southeast Asia Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 183. Southeast Asia Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 185. Southeast Asia Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 187. Middle East Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 190. Middle East Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 192. Middle East Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 194. Africa Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 197. Africa Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 199. Africa Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 201. Oceania Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 204. Oceania Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 206. Oceania Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 208. South America Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 211. South America Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 213. South America Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 215. Rest of the World Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Oncology Companion Diagnostic Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Oncology Companion Diagnostic Market Share (2016-2021)

Table 218. Rest of the World Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Oncology Companion Diagnostic Market Share by Type (2016-2021)

Table 220. Rest of the World Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Oncology Companion Diagnostic Market Share by Application (2016-2021)

Table 222. North America Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 223. East Asia Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 224. Europe Oncology Companion Diagnostic Consumption by Region (2016-2021)

Table 225. South Asia Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 226. Southeast Asia Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 227. Middle East Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 228. Africa Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 229. Oceania Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 230. South America Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 231. Rest of the World Oncology Companion Diagnostic Consumption by Countries (2016-2021)

Table 232. Global Oncology Companion Diagnostic Production Forecast by Region (2022-2027)

Table 233. Global Oncology Companion Diagnostic Sales Volume Forecast by Type (2022-2027)

Table 234. Global Oncology Companion Diagnostic Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Oncology Companion Diagnostic Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Oncology Companion Diagnostic Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Oncology Companion Diagnostic Sales Price Forecast by Type (2022-2027)

Table 238. Global Oncology Companion Diagnostic Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Oncology Companion Diagnostic Consumption Value Forecast by Application (2022-2027)

Table 240. North America Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 241. East Asia Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 242. Europe Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 243. South Asia Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 245. Middle East Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 246. Africa Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 247. Oceania Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 248. South America Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Oncology Companion Diagnostic Consumption Forecast 2022-2027 by Country

Table 250. Global Oncology Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Oncology Companion Diagnostic Revenue Market Share by Type (2016-2021)

Table 252. Global Oncology Companion Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Oncology Companion Diagnostic Revenue Market Share by Type (2022-2027)

Table 254. Global Oncology Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Oncology Companion Diagnostic Revenue Market Share by Application (2016-2021)

Table 256. Global Oncology Companion Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Oncology Companion Diagnostic Revenue Market Share by Application (2022-2027)

Table 258. Oncology Companion Diagnostic Distributors List

Table 259. Oncology Companion Diagnostic Customers List





Figure 1. Product Figure

Figure 2. Global Oncology Companion Diagnostic Market Share by Type: 2021 VS 2027

Figure 3. Global Oncology Companion Diagnostic Market Share by Application: 2021 VS 2027

Figure 4. North America Oncology Companion Diagnostic Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 6. North America Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 7. United States Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 8. Canada Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 12. China Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 13. Japan Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 15. Europe Oncology Companion Diagnostic Consumption and Growth Rate

Figure 16. Europe Oncology Companion Diagnostic Consumption Market Share by Region in 2021

Figure 17. Germany Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 19. France Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 20. Italy Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 21. Russia Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 22. Spain Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 25. Poland Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Oncology Companion Diagnostic Consumption and Growth Rate

Figure 27. South Asia Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 28. India Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Oncology Companion Diagnostic Consumption and Growth Rate

Figure 30. Southeast Asia Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 31. Indonesia Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Oncology Companion Diagnostic Consumption and Growth Rate

Figure 37. Middle East Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 38. Turkey Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 40. Iran Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 42. Africa Oncology Companion Diagnostic Consumption and Growth Rate

Figure 43. Africa Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 44. Nigeria Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Oncology Companion Diagnostic Consumption and Growth Rate

Figure 47. Oceania Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 48. Australia Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 49. South America Oncology Companion Diagnostic Consumption and Growth Rate

Figure 50. South America Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 51. Brazil Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Oncology Companion Diagnostic Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Oncology Companion Diagnostic Consumption and Growth Rate

Figure 54. Rest of the World Oncology Companion Diagnostic Consumption Market Share by Countries in 2021

Figure 55. Global Oncology Companion Diagnostic Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Oncology Companion Diagnostic Price and Trend Forecast (2022-2027)

Figure 58. North America Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 59. North America Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 75. South America Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Oncology Companion Diagnostic Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Oncology Companion Diagnostic Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 79. East Asia Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 80. Europe Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 81. South Asia Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 82. Southeast Asia Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 83. Middle East Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 84. Africa Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 85. Oceania Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 86. South America Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 87. Rest of the world Oncology Companion Diagnostic Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Oncology Companion Diagnostic

Figure 89. Manufacturing Process Analysis of Oncology Companion Diagnostic

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Oncology Companion Diagnostic Supply Chain Analysis